BioPharma Dealmakers June 2016 edition

Our biggest issue of the year is here. The June issue includes over 20 company profiles and 4 feature articles focused around the areas of academic partnering, infectious diseases, industry insight and inflammation.

Like Comment

Read the June 2016 edition of BioPharma Dealmakers....

Read about the companies looking for partnerships from our June edition -

Aeglea Biotherapeutics

Biotest AG

CINVESTAV

Curileum

D3 Medicine

DTU Biosustain-Novo Nordisk Foundation Center for Biosustainability

GSK Vaccines

Helperby

Institut Carnot Calym

Lantern Pharma

Motif Bio

NanoViricides

NIH-National Institute of Allergy and Infectious Diseases (NIAID)

NYU Langone Medical Center- Office of Therapeutics Alliances

Rock Creek

Sanofi Pasteur

Sensor Pharma

The Antibody Lab

The University of Manchester

Ulster University

University of Dundee

Valneva

Verseon

Read the in-depth partnering features from our June edition that compliment the therapeutic and technology areas of the companies above -

Partnerships key to combating viral epidemics

What is the value of a deal?

Dealmaking for inflammatory disorders


Go to the profile of Raveena Bhambra

Raveena Bhambra

Editor, BioPharma Dealmakers , Nature Research

Hello all, I am the Editor of BioPharma Dealmakers, a quarterly publication that assists companies in identifying potential partners in the pharmaceutical and biotechnology industry and appears in both Nature Biotechnology and Nature Reviews Drug Discovery. I am very passionate about the biopharma industry and have over 15 years of experience of working in the field, specifically in dealmaking, partnering and licensing. In my previous roles I have conducted partner searches identifying both products/technologies and partners for clients, and have edited and written dealmaking-focused reports.

No comments yet.